stockrowAlkermes plc
ALKS Healthcare Drug Manufacturers Specialty & Generic
Alkermes plc’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 5.25% from fiscal 2024.
- Revenue
- +21.8%
- EPS
- −80.6%
- Free cash flow
- +6.78%
Quarter to September 2026, against a year earlier
Follow ALKS
Alert me
Alkermes plc (ALKS) Revenue growth
Alkermes plc's revenue growth over the twelve months to 30 September 2026 was 15.3%, up 20.5 percentage points from fiscal 2025 (−5.25%). Over the past ten years it has ranged from −11.3% (fiscal 2020) to 49.6% (fiscal 2023); the current reading is higher than 36% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 5.22% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | −5.25% | 1.11 |
| FY2024 | −6.36% | (55.97) |
| FY2023 | 49.6% | 54.89 |
| FY2022 | −5.28% | (18.28) |
| FY2021 | 13.0% | 24.29 |
| FY2020 | −11.3% | (18.30) |
| FY2019 | 7.01% | (14.12) |
| FY2018 | 21.1% | (0.02) |
| FY2017 | 21.2% | 2.47 |
| FY2016 | 18.7% | 17.14 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 21.8% | (5.17) |
| Jun 2026 | 27.0% | (1.22) |
| Mar 2026 | 28.2% | 38.76 |
| Dec 2025 | −10.6% | (14.81) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| LQDA Liquidia Corporation compare | 2,233.7% |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 58.2% |
| HIMS Hims & Hers Health, Inc. compare | 28.0% |
| SUPN Indivior Pharmaceuticals Inc. compare | 16.4% |
| ALKS Alkermes plc | 15.3% |
| ELAN Elanco Animal Health Incorporated compare | 12.0% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 8.88% |
| LNTH Lantheus Holdings, Inc. compare | 2.38% |
| RDY Dr. Reddy's Laboratories Ltd compare | −15.5% |
| Drug Manufacturers Specialty & Generic industry median | 5.22% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on ALKS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement